Serum thymidine kinase activity in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with palbociclib and fulvestrant

International Breast cancer study group; Breast International Group; PYTHIA Collaborators

Serum thymidine kinase activity in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with palbociclib and fulvestrant

International Breast cancer study group, Breast International Group, PYTHIA Collaborators

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	European Journal of Cancer
Publication status	Published - 13 Feb 2022

Embargoed Document

EJC-D-21-02568_R1 (002)
Accepted author manuscript, 567 KB
Embargo ends: 13/02/23

Cite this

@article{5b1bc32b0586433081b306af86e781a2,

title = "Serum thymidine kinase activity in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with palbociclib and fulvestrant",

author = "{International Breast cancer study group} and {Breast International Group} and {PYTHIA Collaborators} and Luca Malorni and Svitlana Tyekucheva and {S Hilbers}, Florentine and Michail Ignatiadis and Patrick Neven and Marco Colleoni and St{\'e}phanie Henry and Alberto Ballestrero and Andrea Bonetti and Guy Jerusalem and Konstantinos Papadimitriou and Antonio Bernardo and Elena Seles and {P Duhoux}, Francois and {R MacPherson}, Iain and Alastair Thomson and {Mark Davies}, David and Mattias Bergqvist and Ilenia Migliaccio and G{\'e}raldine Gebhart and Gabriele Zoppoli and Bliss, {Judith M} and Matteo Benelli and Amelia McCartney and Roswitha Kammler and {De Swert}, Heidi and Barbara Ruepp and Debora Fumagalli and Rudolf Maibach and Cameron, {David A} and Sherene Loi and Martine Piccart and {M Regan}, Meredith",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Ltd",

year = "2022",

month = feb,

day = "13",

language = "English",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "PERGAMON-ELSEVIER SCIENCE LTD",

}

TY - JOUR

T1 - Serum thymidine kinase activity in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with palbociclib and fulvestrant

AU - International Breast cancer study group

AU - Breast International Group

AU - PYTHIA Collaborators

AU - Malorni, Luca

AU - Tyekucheva, Svitlana

AU - S Hilbers, Florentine

AU - Ignatiadis, Michail

AU - Neven, Patrick

AU - Colleoni, Marco

AU - Henry, Stéphanie

AU - Ballestrero, Alberto

AU - Bonetti, Andrea

AU - Jerusalem, Guy

AU - Papadimitriou, Konstantinos

AU - Bernardo, Antonio

AU - Seles, Elena

AU - P Duhoux, Francois

AU - R MacPherson, Iain

AU - Thomson, Alastair

AU - Mark Davies, David

AU - Bergqvist, Mattias

AU - Migliaccio, Ilenia

AU - Gebhart, Géraldine

AU - Zoppoli, Gabriele

AU - Bliss, Judith M

AU - Benelli, Matteo

AU - McCartney, Amelia

AU - Kammler, Roswitha

AU - De Swert, Heidi

AU - Ruepp, Barbara

AU - Fumagalli, Debora

AU - Maibach, Rudolf

AU - Cameron, David A

AU - Loi, Sherene

AU - Piccart, Martine

AU - M Regan, Meredith

PY - 2022/2/13

Y1 - 2022/2/13

M3 - Article

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -